Performance criteria for the verification of IgE and tryptase assay methods: recommendations from the AllergoBioNet network - Archive ouverte HAL Access content directly
Journal Articles Annales de Biologie Clinique Year : 2020

Performance criteria for the verification of IgE and tryptase assay methods: recommendations from the AllergoBioNet network

(1) , (2) , (3) , (4) , (5) , (6) , (7) , (8) , (9) , (10) , (11) , (12) , , (13) , (14, 15) , (16) , , (17) , (18) , , (19) , (20, 21, 22) , (23) , (24, 25)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
Anne Sarrat
• Function : Author
Rémy Couderc
• Function : Correspondent author
Marie-Alexandra Alyanakian
• Function : Author
Pol-André Apoil
• Function : Author
• PersonId : 1049110
Céline Beauvillain
Pascale Chrétien
• Function : Author
Arnaud Ciree
• Function : Author
Bertrand Evrard
Lorna Garnier
• Function : Author
Angelique Grenier
• Function : Author
Valérie Guérin
Anthony Leon
• Function : Author
Delphine Mariotte
• Function : Author
Stephanie Rogeau
• Function : Author
Thierry Tabary
• Function : Author
Mylène Vivinus
• Function : Author
Joana Vitte

Abstract

Accreditation of an in vitro diagnostic assay according to the NHENI/ISO 15189 standard requires to analyze its technical performance before implementation for routine use, and annually when reviewing effectiveness of quality controls. Performance is evaluated through repeatability, intermediate fidelity, accuracy and uncertainty of measurement. The coefficients of variation (CV) of the infra-assay and inter-assay precision tests must be compared with those of peers'' (results from laboratories employing the same method) and also with those obtained with all methods'', i.e., results from all laboratories performing the same assay, irrespective of the method. To our best knowledge, there is currently no French or international recommendation on what the acceptable limits of performance for specific IgE and tryptase assays should be. Therefore, the AllergoBioNet network of hospital allergy laboratories set out to characterize the performance of their current methods as a basis for the development of recommendations. The results provided by 24 centers were analyzed and led to consensus recommendations for specific IgE, total and tryptase assays.

Domains

Life Sciences [q-bio]

Dates and versions

hal-03150166 , version 1 (23-02-2021)

Identifiers

• HAL Id : hal-03150166 , version 1
• DOI :
• PUBMED :

Cite

Anne Sarrat, Rémy Couderc, Marie-Alexandra Alyanakian, Pol-André Apoil, Céline Beauvillain, et al.. Performance criteria for the verification of IgE and tryptase assay methods: recommendations from the AllergoBioNet network. Annales de Biologie Clinique, 2020, 78 (3), pp.329-342. ⟨10.1684/abc.2020.1549⟩. ⟨hal-03150166⟩

80 View